Trastuzumab is a monoclonal antibody targeted against the human epidermal growth factor receptor (HER) 2 tyrosine kinase receptor, which is overexpressed in approximately 25% of invasive breast ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback